2BFM | Oxidoreductase | date | Dec 09, 2004 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Leishmania Major Pteridine Reductase 1 In Complex With Nadp Trimethoprim | ||||||||||||||
authors | A.W.Schuettelkopf, W.N.Hunter | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Pteridine Reductase 1 Chain: A, B, C, D Synonym: H Region Methotrexate Resistance Protein Ec: 1.5.1.33 Engineered: Yes |
Organism_scientific: Leishmania Major Organism_taxid: 5664 Expression_system: Escherichia Coli Expression_system_taxid: 469008 Expression_system_strain: Bl21(De3) Expression_system_plasmid: Pet 15b | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 Å | ||||||||||||
ligand | NDP, TOP | enzyme | Oxidoreductase E.C.1.5.1.33 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design., Schuttelkopf AW, Hardy LW, Beverley SM, Hunter WN, J Mol Biol. 2005 Sep 9;352(1):105-16. PMID:16055151 |
Data retrieval |
View 2BFM in 3D |
Visual 3D analysis of 2BFM |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2BFM |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |